Related Experiment Video
Updated: Jun 8, 2026

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
Published on: September 9, 2012
Prospective evaluation of three different diagnostic criteria for disseminated intravascular coagulation
Takemitsu Takemitsu1, Hideo Wada, Tsuyoshi Hatada
1Department of Hematology and Oncology, Mie University Graduate School of Medicine, Tsu, Japan.
Insights
Three diagnostic criteria for disseminated intravascular coagulation (DIC) were evaluated. All systems showed a link to poor patient outcomes, with varying sensitivity and specificity for diagnosing DIC.
Area of Science:
- Hematology
- Critical Care Medicine
- Clinical Diagnostics
Background:
- Disseminated intravascular coagulation (DIC) diagnosis relies on multiple scoring systems.
- Established criteria include those from the Japanese Ministry Health and Welfare (JMHW), the International Society on Thrombosis and Haemostasis (ISTH), and the Japanese Association for Acute Medicine (JAAM).
- The JMHW criteria remain in use within Japan.
Purpose of the Study:
- To prospectively evaluate and compare the diagnostic performance and prognostic value of three established DIC scoring systems.
- To assess the utility of haemostatic molecular markers in DIC diagnosis.
Main Methods:
- Prospective evaluation of 413 patients with various underlying DIC causes at Mie University Hospital.
- Application of JMHW, ISTH, and JAAM diagnostic criteria to patient cohorts.
- Statistical analysis of diagnostic criteria performance, including odds ratios for mortality and assessment of key laboratory markers.
Main Results:
- All three criteria (JMHW, ISTH, JAAM) were significantly associated with poor patient outcomes (odds ratios for death: 1.88, 2.55, 1.99, respectively).
- Platelet count, prothrombin time, fibrin/fibrinogen degradation products, and fibrinogen levels were crucial for DIC diagnosis across all systems.
- JAAM criteria demonstrated high sensitivity, while ISTH overt-DIC criteria showed high specificity for DIC diagnosis.
- Elevated haemostatic molecular markers were consistently observed and proved useful for DIC diagnosis.
Conclusions:
- All evaluated DIC diagnostic criteria are linked to adverse patient prognoses.
- The JAAM and ISTH criteria offer distinct advantages in sensitivity and specificity, respectively.
- Standard laboratory markers and haemostatic markers are vital components in the comprehensive diagnosis of DIC.
Abstract:
There are three different diagnostic score systems for disseminated intravascular coagulation (DIC) established by the Japanese Ministry Health and Welfare (JMHW), the International Society on Thrombosis and Haemostasis (ISTH) and the Japanese Association for Acute Medicine (JAAM). The JMHW criteria are still used in Japan. In the present study, all three diagnostic criteria were used to prospectively evaluate 413 patients with different underlying diseases of DIC who were treated at the Mie University Hospital (JMHW, n= 166; ISTH, n=143; JAAM, n=291). The odds ratio (95% confidence interval) for death was 1.88 (1.22 - 2.90) in JMHW, 2.55 (1.65 - 3.95) in ISHT and 1.99 (1.19 - 3.32) in JAAM. The platelet count, prothrombin time, fibrin and fibrinogen degradation products and fibrinogen were significantly important for diagnosis of DIC by all three diagnostic criteria. Haemostatic molecular markers were significantly high in all patients and were useful for the diagnosis of DIC. The JAAM diagnostic criteria displayed a high sensitivity for DIC and the ISTH overt-DIC diagnostic criteria displayed a high specificity for DIC. All three diagnostic criteria for DIC were related to a poor patient outcome.
Related Concept Videos
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Acute Coronary Syndrome III: Diagnostic Studies
Venous Thrombosis III: Interprofessional Care
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
